GSK reaches settlement in another Zantac case
(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.
Read moreWed, 20th Nov 2013 08:19
(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.
Read more(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.
Read more(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.
Read more(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.
Read more(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.
Read more(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.
Read moreDiageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."
Read moreFriday 16 February | |
JPMorgan Asia Growth & Income PLC | dividend payment date |
JPMorgan Japan Small Cap Growth & Income PLC | dividend payment date |
Murray International Trust PLC | dividend payment date |
Premier Miton Group PLC | dividend payment date |
Schroder Oriental Income Fund | dividend payment date |
Solid State PLC | dividend payment date |
Monday 19 February | |
no events scheduled | |
Tuesday 20 February | |
Invesco Bond Income Plus Ltd | |
Wednesday 21 February | |
no events scheduled | |
Thursday 22 February | |
abrdn Asia Focus PLC | ex-dividend payment date |
Alumasc Group PLC | ex-dividend payment date |
AstraZeneca PLC | ex-dividend payment date |
BlackRock Throgmorton Trust PLC | ex-dividend payment date |
Braemar PLC | ex-dividend payment date |
easyJet PLC | ex-dividend payment date |
Ecofin US Renewables Infrastructure Trust PLC | ex-dividend payment date |
Endeavour Mining PLC | ex-dividend payment date |
FRP Advisory Group PLC | ex-dividend payment date |
Gateley Holdings PLC | ex-dividend payment date |
GSK PLC | ex-dividend payment date |
Hercules Site Services PLC | ex-dividend payment date |
Jersey Electricity PLC | ex-dividend payment date |
Land Securities Group PLC | ex-dividend payment date |
Molten Ventures VCT PLC | ex-dividend payment date |
Northern Bear PLC | ex-dividend payment date |
Redrow PLC | ex-dividend payment date |
Samuel Heath & Sons PLC | ex-dividend payment date |
Titon Holdings PLC | ex-dividend payment date |
Unilever PLC | ex-dividend payment date |
Van Elle Holdings PLC | ex-dividend payment date |
Virgin Money UK PLC | ex-dividend payment date |
Witan Investment Trust PLC | ex-dividend payment date |
Comments and questions to newsroom@alliancenews.com | |
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
Copyright 2024 Alliance News Ltd. All Rights Reserved. |
(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.
Read more(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.
Read more(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.
Read more(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.
Read more(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.
Read more